Epidemiological Study Regarding the Incidence of Venous Thromboembolism in Patients After Cancer Remission.

Published in: Cardiology and therapy (2022)

Risk of developing VTE decreased to the same level as that in patients without cancer 2 years after cancer remission. Although the guidelines do not specify the duration of anticoagulant prophylaxis for new onset or recurrent VTE after cancer remission and the appropriate duration of such prophylaxis may vary depending on VTE risk factors, determining the period of high risk of VTE for each patient and preventing VTE is considered important.

Keyphrases

venous thromboembolism
papillary thyroid
direct oral anticoagulants
risk factors
squamous cell
ejection fraction
newly diagnosed
prognostic factors
disease activity
case report
childhood cancer
clinical practice
ulcerative colitis